Chi-Meng Tzeng

1.9k total citations
63 papers, 1.4k citations indexed

About

Chi-Meng Tzeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chi-Meng Tzeng has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Chi-Meng Tzeng's work include RNA regulation and disease (9 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (6 papers). Chi-Meng Tzeng is often cited by papers focused on RNA regulation and disease (9 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (6 papers). Chi-Meng Tzeng collaborates with scholars based in China, Taiwan and New Zealand. Chi-Meng Tzeng's co-authors include Qing Lin, Ye Zhao, Hsin‐Chih Lai, Wen-Qing Huang, Tzu-Lung Lin, Wei-Fan Lai, Chia‐Chen Lu, Long Gu, Xuan Zhuang and Zhiming Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Scientific Reports.

In The Last Decade

Chi-Meng Tzeng

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi-Meng Tzeng China 20 800 228 161 138 124 63 1.4k
Rong‐Hong Hsieh Taiwan 24 938 1.2× 226 1.0× 130 0.8× 118 0.9× 93 0.8× 62 1.7k
Sanghee Park United States 26 723 0.9× 172 0.8× 98 0.6× 72 0.5× 87 0.7× 92 1.7k
Tingting Fang China 26 825 1.0× 312 1.4× 191 1.2× 176 1.3× 143 1.2× 82 1.6k
Jianwei Liu China 21 692 0.9× 106 0.5× 135 0.8× 134 1.0× 71 0.6× 72 1.7k
Wei Peng China 23 529 0.7× 160 0.7× 176 1.1× 120 0.9× 131 1.1× 49 1.1k
Yali Zhang China 25 1.1k 1.3× 413 1.8× 244 1.5× 123 0.9× 115 0.9× 121 1.9k
Dongsheng Li China 23 1.0k 1.3× 329 1.4× 131 0.8× 113 0.8× 92 0.7× 95 1.8k
Mingxia Zhou China 19 911 1.1× 400 1.8× 127 0.8× 231 1.7× 92 0.7× 49 1.4k

Countries citing papers authored by Chi-Meng Tzeng

Since Specialization
Citations

This map shows the geographic impact of Chi-Meng Tzeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Meng Tzeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Meng Tzeng more than expected).

Fields of papers citing papers by Chi-Meng Tzeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Meng Tzeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Meng Tzeng. The network helps show where Chi-Meng Tzeng may publish in the future.

Co-authorship network of co-authors of Chi-Meng Tzeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Meng Tzeng. A scholar is included among the top collaborators of Chi-Meng Tzeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Meng Tzeng. Chi-Meng Tzeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xueting, et al.. (2025). Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles. Cell Transplantation. 34. 4241355479–4241355479. 3 indexed citations
2.
Chen, Ziyi, et al.. (2023). Alloferon-1 ameliorates estrogen deficiency-induced osteoporosis through dampening the NLRP3/caspase-1/IL-1β/IL-18 signaling pathway. International Immunopharmacology. 124(Pt B). 110954–110954. 15 indexed citations
3.
Zhao, Ye, et al.. (2023). Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals. Journal of Cell Communication and Signaling. 17(4). 1335–1354. 6 indexed citations
4.
Wang, Huiling, et al.. (2023). Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles. International Journal of Molecular Sciences. 24(3). 2053–2053. 8 indexed citations
5.
Zhao, Ye, et al.. (2022). Talin‑1 interaction network in cellular mechanotransduction (Review). International Journal of Molecular Medicine. 49(5). 26 indexed citations
6.
Zhao, Ye, Huiling Wang, Tongtong Li, Fei Yang, & Chi-Meng Tzeng. (2020). <p>Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway</p>. Drug Design Development and Therapy. Volume 14. 195–206. 73 indexed citations
7.
Zhao, Ye, Huiling Wang, Qing Lin, et al.. (2020). Identification of hsa-miR-1275 as a Novel Biomarker Targeting MECP2 for Human Epilepsy of Unknown Etiology. Molecular Therapy — Methods & Clinical Development. 19. 398–410. 6 indexed citations
8.
Zhao, Ye, Liangliang Cai, Huiling Wang, et al.. (2019). <p>1,25-Dihydroxyvitamin D<sub>3</sub> affects gastric cancer progression by repressing BMP3 promoter methylation</p>. OncoTargets and Therapy. Volume 12. 2343–2353. 5 indexed citations
9.
Li, Zhiming, et al.. (2018). Novel biomarker ZCCHC13 revealed by integrating DNA methylation and mRNA expression data in non-obstructive azoospermia. Cell Death Discovery. 4(1). 36–36. 17 indexed citations
10.
Cai, Liangliang, Wen-Qing Huang, Zhiying Su, et al.. (2017). Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population. Scientific Reports. 7(1). 17379–17379. 4 indexed citations
11.
Li, Zhiming & Chi-Meng Tzeng. (2017). Integrated Analysis of miRNA and mRNA Expression Profiles to Identify miRNA Targets. Methods in molecular biology. 1720. 141–148. 13 indexed citations
12.
Li, Zhiming, Li Zhong, Long Gu, et al.. (2016). Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese population. BMJ Open. 6(1). e009499–e009499. 12 indexed citations
13.
Huang, Wen-Qing, Ya Zhang, Liangliang Cai, et al.. (2016). A Novel CCM2 Gene Mutation Associated with Familial Cerebral Cavernous Malformation. Frontiers in Aging Neuroscience. 8. 220–220. 9 indexed citations
14.
Li, Zhiming, et al.. (2016). Herba Cistanche (Rou Cong-Rong): One of the Best Pharmaceutical Gifts of Traditional Chinese Medicine. Frontiers in Pharmacology. 7. 41–41. 92 indexed citations
15.
Li, Zhiming, et al.. (2016). Chronic Inflammation Links Cancer and Parkinson’s Disease. Frontiers in Aging Neuroscience. 8. 126–126. 40 indexed citations
16.
Li, Zhiming, Qing Lin, Wen-Qing Huang, & Chi-Meng Tzeng. (2015). Target Gene Capture Sequencing in Chinese Population of Sporadic Parkinson Disease. Medicine. 94(20). e836–e836. 5 indexed citations
17.
Huang, Wen-Qing, Qing Lin, Xuan Zhuang, et al.. (2014). Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis. Current Cancer Drug Targets. 14(6). 567–588. 62 indexed citations
18.
Cai, Liangliang, et al.. (2013). 25-(OH)VitD<sub>3</sub>, as a Risk Indicator in Diagnosis of Adenocarcinoma. Current Drug Targets. 14(11). 1367–1376. 2 indexed citations
19.
Lin, Eugene, et al.. (2006). A Case Study of the Utility of the HapMap Database for Pharmacogenomic Haplotype Analysis in the Taiwanese Population. Molecular Diagnosis & Therapy. 10(6). 367–370. 15 indexed citations
20.
Yang, Ning‐Sun, et al.. (2004). Medicinal Herb Extract and a Single-Compound Drug Confer Similar Complex Pharmacogenomic Activities in MCF-7 Cells. Journal of Biomedical Science. 11(3). 418–422. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rong‐Hong Hsieh Breakdown of academic impact, for papers by Sanghee Park Breakdown of academic impact, for papers by Tingting Fang Breakdown of academic impact, for papers by Jianwei Liu Breakdown of academic impact, for papers by Wei Peng Breakdown of academic impact, for papers by Yali Zhang Breakdown of academic impact, for papers by Dongsheng Li Breakdown of academic impact, for papers by Mingxia Zhou
Rankless by CCL
2026